| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-05 |